{"id":"https://openalex.org/W72488166","doi":null,"title":"New Business Models for Sustainable Antibiotics","display_name":"New Business Models for Sustainable Antibiotics","publication_year":2014,"publication_date":"2014-02-01","ids":{"openalex":"https://openalex.org/W72488166","mag":"72488166"},"language":"en","primary_location":{"id":"mag:72488166","doi":null,"is_oa":true,"landing_page_url":"https://petrieflom.law.harvard.edu/assets/publications/Outterson_Health_Law_Workshop_paper.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SSRN Electronic Journal","raw_type":null},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://petrieflom.law.harvard.edu/assets/publications/Outterson_Health_Law_Workshop_paper.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056587472","display_name":"Kevin Outterson","orcid":"https://orcid.org/0000-0003-2513-3216","observed_orcids":["https://orcid.org/0000-0003-2513-3216"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kevin Outterson","raw_affiliation_strings":["Boston University - School of Law"],"raw_orcid":"https://orcid.org/0000-0003-2513-3216","affiliations":[{"raw_affiliation_string":"Boston University - School of Law","institution_ids":["https://openalex.org/I111088046"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5056587472"],"corresponding_institution_ids":["https://openalex.org/I111088046"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.050200000405311584,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/business-models","display_name":"business models","score":0.7440000176429749},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.796999990940094},{"id":"https://openalex.org/keywords/overuse-of-antibiotics","display_name":"antibiotic overuse","score":0.5809999704360962},{"id":"https://openalex.org/keywords/market-incentives","display_name":"market incentives","score":0.7630000114440918},{"id":"https://openalex.org/keywords/antibiotic-access","display_name":"antibiotic access","score":0.7049999833106995},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.45100000500679016},{"id":"https://openalex.org/keywords/sustainable-resource-management","display_name":"sustainable resource management","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.7691047787666321},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6618709564208984},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4730364978313446},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.4511519968509674},{"id":"https://openalex.org/C206345919","wikidata":"https://www.wikidata.org/wiki/Q20380951","display_name":"Resource (disambiguation)","level":2,"score":0.4154636263847351},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.4041227400302887},{"id":"https://openalex.org/C175605778","wikidata":"https://www.wikidata.org/wiki/Q3299701","display_name":"Natural resource economics","level":1,"score":0.34419113397598267},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3411622643470764},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2756350040435791},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.22929462790489197},{"id":"https://openalex.org/C34447519","wikidata":"https://www.wikidata.org/wiki/Q179522","display_name":"Market economy","level":1,"score":0.12781286239624023},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:72488166","doi":null,"is_oa":true,"landing_page_url":"https://petrieflom.law.harvard.edu/assets/publications/Outterson_Health_Law_Workshop_paper.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SSRN Electronic Journal","raw_type":null}],"best_oa_location":{"id":"mag:72488166","doi":null,"is_oa":true,"landing_page_url":"https://petrieflom.law.harvard.edu/assets/publications/Outterson_Health_Law_Workshop_paper.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"SSRN Electronic Journal","raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.46810001134872437,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W1980467288"],"related_works":["https://openalex.org/W3124516761","https://openalex.org/W1949382668","https://openalex.org/W2884690207","https://openalex.org/W4256592006","https://openalex.org/W2302618685","https://openalex.org/W3128541845","https://openalex.org/W2996030696","https://openalex.org/W7128960647","https://openalex.org/W2883031947","https://openalex.org/W1980433906"],"abstract_inverted_index":{"Antibiotics":[0,46],"are":[1,47,66,76,177],"powerful":[2],"drugs":[3,103,164,183],"that":[4,52,97,114,215],"prevent":[5],"many":[6],"deaths":[7],"each":[8],"year.":[9],"Modern":[10],"medicine":[11],"relies":[12],"on":[13,56,220,261],"them":[14],"as":[15],"a":[16,40,48,57,70,209,244],"safety":[17],"net.":[18],"Many":[19,111],"invasive":[20],"medical":[21],"procedures":[22],"would":[23,36],"be":[24,37,54,124,193],"much":[25],"more":[26],"dangerous":[27],"without":[28],"effective":[29],"antibiotics.":[30,262],"Global":[31],"trade,":[32],"travel":[33],"and":[34,89,104,136,149,197,218,254],"security":[35],"threatened":[38],"by":[39],"resurgence":[41],"of":[42,101,223,246],"untreatable":[43],"infectious":[44],"diseases.":[45],"precious":[49],"global":[50,158,211],"resource":[51],"must":[53,192],"managed":[55,68],"sustainable":[58,194],"ecological":[59],"basis,":[60],"akin":[61],"to":[62,78,107,128,142,156,160,243],"fisheries.But":[63],"today,":[64],"antibiotics":[65],"either":[67],"in":[69,188,236],"haphazard":[71],"fashion":[72],"or":[73,121,180],"mismanaged.":[74],"They":[75],"vulnerable":[77],"premature":[79,150],"destruction":[80],"through":[81],"resistance.":[82],"Physicians,":[83],"hospitals,":[84],"drug":[85],"companies,":[86],"payers,":[87],"patients":[88,187],"food":[90],"producers":[91,217],"often":[92],"face":[93],"perverse":[94],"financial":[95],"incentives":[96,106,141,155,173],"encourage":[98],"inappropriate":[99,175],"use":[100,176],"these":[102,144],"undercut":[105],"create":[108],"new":[109,163],"ones.":[110],"stakeholders":[112],"believe":[113],"an":[115],"antibiotic":[116,134,233],"crisis":[117],"is":[118,225],"fast":[119],"approaching":[120],"may":[122,202],"already":[123],"upon":[125],"us.":[126],"Owing":[127],"the":[129,171,182,199,204,221,232,237],"long":[130],"lead":[131],"times":[132],"for":[133,174,208],"research":[135],"development":[137],"(RD\u25cf":[138],"Inadequate":[139,153],"market":[140,154],"protect":[143],"valuable":[145],"resources":[146],"from":[147],"overuse":[148],"resistance;":[151],"and\u25cf":[152],"ensure":[157],"access":[159],"life-saving":[161],"antibiotics.Creating":[162],"will":[165],"achieve":[166],"no":[167],"lasting":[168],"success":[169],"if":[170,181],"underlying":[172],"not":[178,185],"addressed,":[179],"do":[184],"reach":[186],"need.":[189],"The":[190],"solution":[191],"over":[195],"generations":[196],"across":[198],"planet.Antibiotic":[200],"delinkage":[201,234],"offer":[203],"most":[205],"promising":[206],"avenue":[207],"sustainable,":[210],"approach.":[212],"Delinkage":[213],"recognizes":[214],"rewarding":[216],"sellers":[219],"basis":[222],"volume":[224],"fundamentally":[226],"inappropriate.":[227],"This":[228],"paper":[229,258],"explores":[230],"all":[231],"models":[235],"existing":[238],"literature,":[239],"bringing":[240],"some":[241],"order":[242],"variety":[245],"proposals.":[247],"While":[248],"resistance":[249],"affects":[250],"antibiotics,":[251],"antivirals,":[252],"antiretrovirals":[253],"antifungal":[255],"agents,":[256],"this":[257],"focuses":[259],"primarily":[260]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}